Ondansetron and oral rehydration therapy in pediatric patients with dehydration a review of clinical effectiveness
The objective of this review was to summarize the evidence surrounding the clinical effectiveness of ondansetron for pediatric patients with or at risk of mild to moderate dehydration. For the purposes of this report, dehydration is categorized as mild to moderate according to the definitions used w...
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2020, February 14, 2020
|
| Edition: | Version: 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The objective of this review was to summarize the evidence surrounding the clinical effectiveness of ondansetron for pediatric patients with or at risk of mild to moderate dehydration. For the purposes of this report, dehydration is categorized as mild to moderate according to the definitions used within the included studies. The population considered to be "at risk" of dehydration includes those who do not meet the criteria for mild or moderate dehydration according to the study definition but in whom oral rehydration therapy is deemed necessary |
|---|---|
| Physical Description: | 1 PDF file (21 pages) illustration |